ライフサイエンスコーパス: lipid emulsion

1 tandard dose) of total daily energy as a 20% lipid emulsion.

2 ability of phylloquinone from an intravenous lipid emulsion.

3 n containing 10% fish oil or a fish oil-free lipid emulsion.

4 l pressure was observed in rats treated with lipid emulsion.

5 c arrest before and after resuscitation with lipid emulsion.

6 cue of bupivacaine-induced cardiotoxicity by lipid emulsion.

7 shown for this treatment nor for the type of lipid emulsion.

8 esent naturally, in variable amounts, in the lipid emulsion.

9 rly in low-birth-weight neonates who receive lipid emulsions.

10 iled characterization of the in vivo fate of lipid emulsions.

11 ess to bitter-tasting stimuli, as well as to lipid emulsions.

12 (Intralipid) or olive oil-based (ClinOleic) lipid emulsions.

13 r amino acid intakes and fish oil-containing lipid emulsions.

14 and avoidance of complications from amended lipid emulsions.

15 of the following 4 different fat emulsions: lipid emulsion 1 (LE1; acid stable, 0.33 mum), lipid emu

16 one patients (81%) received a fish oil-based lipid emulsion (1 g/kg/d), 40 (63%) were weaned, 11 (17%

17 ment with one of the following: intraosseous lipid-emulsion (10 mL/kg over 180 s), intraosseous salin

18 ntraosseous saline (10 mL/kg over 180 s), IV lipid-emulsion (10 mL/kg over 90 s), or no treatment (sh

19 at a similar rate to animals treated with IV lipid emulsion (176 s [152-217 s], p = not significant).

20 pid emulsion 1 (LE1; acid stable, 0.33 mum), lipid emulsion 2 (LE2; acid stable, 52 mum), lipid emuls

21 lipid emulsion 2 (LE2; acid stable, 52 mum), lipid emulsion 3 (LE3; acid unstable, solid fat, 0.32 mu

22 E3; acid unstable, solid fat, 0.32 mum), and lipid emulsion 4 (LE4; acid unstable, liquid fat, 0.38 m

23 d radiolabeled triglyceride derived from the lipid emulsion (a surrogate for chylomicrons; extraction

24 n compared to the group that did not receive Lipid Emulsion after bupivacaine overdose (330+/-42 nmol

25 using infusions of a [(3)H]triolein-labeled lipid emulsion and [U-(13)C]oleate during continuous fee

26 stricting the dose of parenteral soybean oil lipid emulsion and/or replacing the soybean oil with a p

27 eous lipid emulsion, intraosseous saline, IV lipid emulsion, and sham/null.

28 New details on the effects of amended lipid emulsions are presented, together with a meta-anal

29 3)H triolein, the latter incorporated into a lipid emulsion as a surrogate for chylomicrons.

30 inical reports have led to the acceptance of lipid emulsion as an effective treatment of local anesth

31 Glucagon-like peptide-2, and lipid emulsions based less on soy-bean oil appear safe a

32 rapy, rescues behavioral responsiveness to a lipid emulsion but not to bitter stimuli and that this r

33 Bolus infusion of lipid emulsion can reverse cardiac pharmacotoxicity caus

34 Lipid emulsions, choline deficiency, and manganese toxic

35 ria isolated from rats resuscitated with 20% lipid emulsion compared to the group that did not receiv

36 amics of binding of apoA-I to lipid, we used lipid emulsions composed of triolein (TO) and egg phosph

37 this effect, rats were infused with either a lipid emulsion (consisting mostly of 18:2 fatty acids) o

38 parenteral nutrition prepared either with a lipid emulsion containing 10% fish oil or a fish oil-fre

39 sition and 2) the effect of a multicomponent lipid emulsion containing 30% soybean oil, 30% medium-ch

40 A lipid emulsion containing 4 mm phospholipid, 13.33 mm [(

41 -h fast during infusion of [14C]oleate and a lipid emulsion containing [3H]triolein; the emulsion was

42 Combination lipid emulsions containing fish oil are associated with

43 The effects of lipid emulsions containing medium-chain triglycerides, c

44 Subjects received infusions of lipid emulsions containing triolein labeled with (3)H on

45 cosa, and triggering drug precipitation upon lipid emulsion depletion (e.g., by digestion).

46 in which mice are trained to self-administer lipid emulsions directly into the stomach, we show that

47 Lipid emulsion exerts rapid, positive inotropic and posi

48 Rats treated with intraosseous lipid emulsion experienced a significantly faster recove

49 recent literature involving a fish oil-based lipid emulsion (FOLE) and its effects on PNALD.

50 A fish-oil-based lipid emulsion (FOLE) as a component of PN can reverse P

51 1) assess the effect on iron absorption of a lipid emulsion given 20 min before or together with an i

52 n erythrocytes 14 d after the test meals.The lipid emulsion given either before or with the meal sign

53 Lipid emulsion has been shown to be effective in resusci

54 Furthermore, lipid emulsion has been used with apparent success early

55 Lipid emulsion has emerged as an effective treatment of

56 The role of lipid emulsion has expanded to treatment of cardiac toxi

57 orial in etiology, components of soybean oil lipid emulsions have been implicated in the disease's pa

58 and efficacy of a fish oil-based intravenous lipid emulsion (ILE) in the treatment of parenteral nutr

59 ately 0.3 mM) was prevented by infusion of a lipid emulsion in 15 conscious rats (plasma FFA approxim

60 d with (LIP+) and without (LIP-) infusion of lipid emulsion in nine nondiabetic individuals.

61 otal of 51 patients received olive oil-based lipid emulsion in parenteral nutrition (age 46 +/- 19 yr

62 A FOLE may be the preferred lipid emulsion in patients with PN-cholestasis, dyslipid

63 cue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats.

64 The infusion of lipid emulsion in the isolated heart dose-dependently in

65 Lipid emulsion in this rat model provides superior hemod

66 The use of intravenous lipid emulsions in preterm infants has been limited by c

67 Lipid emulsions increased the DNA-binding activity of NF

68 0 mg/kg over 20 secs, intravenously) and 20% lipid emulsion infusion (5 mL/kg bolus, and 0.5 mL/kg/mi

69 Lipid emulsion infusion appears to be an effective treat

70 The authors test the hypothesis that lipid emulsion infusion exerts direct, positive inotropi

71 Lipid Emulsion infusion improved the cardiac function gr

72 Lipid emulsion infusion is an emerging antidotal therapy

73 tion from bupivacaine-induced asystole using lipid emulsion infusion vs. vasopressin, alone and with

74 ne group before and after resuscitation with lipid emulsion infusion.

75 (-1). min(-1)), and Liposyn (heparinized 10% lipid emulsion) infusions were initiated simultaneously

76 re warranted to optimize this novel route of lipid emulsion injection in emergency situations when in

77 using chylomicrons as well as the synthetic lipid emulsion Intralipid.

78 e-Dawley rats into four groups: intraosseous lipid emulsion, intraosseous saline, IV lipid emulsion,

79 oxicity occurs primarily at sodium channels, lipid emulsion is a reasonably well tolerated and effect

80 compressions, and randomized to receive 30% lipid emulsion (L, 5 mL/kg bolus then 1.0 mL/kg/min infu

81 (14)C oleate and a lipid emulsion labeled with (3)H triolein were infused t

82 istration of parenteral nutrition, including lipid emulsion (LE), to patients via medical catheters i

83 eral nutrition (PN) with vegetable oil-based lipid emulsions (LEs).

84 ultures of rat hepatocytes were treated with lipid emulsions, linoleic or oleic acid, and UCP-2 expre

85 Recently, we have shown that intravenous lipid emulsion (liposyn) infusion during a 120-min eugly

86 riod 2, saline (nicotinic acid [NA], n = 7), lipid emulsion (NA plus lipid emulsion [NAL], n = 8), or

87 c acid [NA], n = 7), lipid emulsion (NA plus lipid emulsion [NAL], n = 8), or glycerol (NA plus glyce

88 l (SMOF) with that of soybean oil (SO)-based lipid emulsion on intrahepatocellular lipid (IHCL) conte

89 The acute effects of lipid emulsions on gastric emptying, gallbladder volume,

90 g the soybean oil with a parenteral fish-oil lipid emulsion or emulsions of mixed-lipid sources.

91 photericin B delivered as a locally prepared lipid emulsion or in liposomes reduced nephrotoxicity to

92 data to warrant wholesale switching to novel lipid emulsions or the global use of glutamine or growth

93 Here, we infused 20% Intralipid (a synthetic lipid emulsion) or saline intraduodenally for 90 min at

94 -III molecule are critical for attachment to lipid emulsion particles and consequently inhibition of

95 articles (phospholipid unilamellar vesicles, lipid emulsion particles) gave rise to stoichiometric li

96 III inhibit lipolysis by displacing LPL from lipid emulsion particles.

97 data indicate that intraosseous infusion of lipid emulsion rapidly reverses bupivacaine-induced card

98 aining soybean oil-based and olive oil-based lipid emulsion resulted in similar rates of infectious a

99 ding fat administered as a soybean oil-based lipid emulsion (SOLE), is a life-saving therapy but may

100 By assessing different lipid emulsions (soy lecithin, milkfat globule membrane

101 t is more effectively treated by intravenous lipid emulsion than by epinephrine.

102 The next day, the infusate was changed to a lipid emulsion that contained (14C) cholesterol and (3H)

103 rmine whether early initiation of lipids and lipid emulsions that are not purely soybean oil-based re

104 proinflammatory effects of soybean oil-based lipid emulsions, the only Food and Drug Administration-a

105 of a patient successfully resuscitated with lipid emulsion therapy after prolonged and intractable l

106 te a case report involving successful use of lipid emulsion therapy for intractable cardiac arrest du

107 This case demonstrates the need to consider lipid emulsion therapy in the advanced cardiac life supp

108 The mechanism of action of lipid emulsion therapy is not well defined and has been

109 lation, oxygenation, and chest compressions, lipid emulsion therapy should be a primary element in th

110 ental doses of high-dose insulin (1D) and IV lipid-emulsion therapy (1D) if not already tried.

111 standard advanced cardiac life-support (1D), lipid-emulsion therapy (1D), and we suggest venoarterial

112 f myocardial dysfunction is present (2D), IV lipid-emulsion therapy (2D), and using a pacemaker in th

113 Study 2 used an intravenous lipid emulsion to increase FFA concentrations during inf

114 ement of intragastric self-administration of lipid emulsions to determine the extent to which postora

115 Vegetable oil-based lipid emulsions (VBLEs) contribute to PNALD.

116 In studies 1 and 2, a lipid emulsion was given with or 20 min before the meal.

117 Lipid emulsion was only able to rescue rats pretreated w

118 A drop of the lipid emulsion was then instilled; 15 minutes later, two

119 We questioned whether the catabolism of lipid emulsions would be changed after enrichment with f